Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jordan Hannink Attal"'
Autor:
Yehuda Neumark, Jordan Hannink Attal, Naham Shapiro, Fiona MacLeod, Janas Harrington, Paul Barach, Jascha de Nooijer, Keren Dopelt, Mariusz Duplaga, Lore Leighton, Hagai Levine, Zohar Mor, Robert Otok, Stephanie Paillard-Borg, Ted Tulchinsky, Shira Zelber-Sagi, Maureen Malowany
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
AimCompetency frameworks are essential for analyzing capabilities of Schools of Public Health to adequately prepare public health (PH) professionals to address contemporary challenges. This study maps the competency profiles of PH training programs i
Externí odkaz:
https://doaj.org/article/c818e07bae464815939775f4c5183ae9
Autor:
Alexander Rouvinski, Ahuva Friedman, Saveliy Kirillov, Jordan Hannink Attal, Sujata Kumari, Jamal Fahoum, Reuven Wiener, Sophie Magen, Yevgeni Plotkin, Daniel Chemtob, Herve Bercovier
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-11 (2023)
Abstract The humoral response after the fourth dose of a mRNA vaccine against COVID-19 has not been adequately described in elderly recipients, particularly those not exposed previously to SARS-CoV-2. Serum anti-RBD IgG levels (Abbott SARS-CoV-2 IgG
Externí odkaz:
https://doaj.org/article/69404afee59e494c9a707e00d24eb698
Publikováno v:
Journal of Migration and Health, Vol 10, Iss , Pp 100263- (2024)
Background: In 2018, 66,859 migrant careworkers were in Israel, most of whom originated from Southeast Asian countries and 81 % of whom are women. Stringent regulations combined with social invisibility creates vulnerabilities that may contribute to
Externí odkaz:
https://doaj.org/article/81a70a11c29f4c5a8ad9062c4ff9d45a
Publikováno v:
Israel Journal of Health Policy Research, Vol 9, Iss 1, Pp 1-11 (2020)
Abstract Background Israel hosts nearly 70,000 migrant careworkers. Migrant careworkers work and live with populations extremely vulnerable to the novel Coronavirus, including the elderly and people with pre-existing physical conditions. This rapid a
Externí odkaz:
https://doaj.org/article/5aae8f19becd4697bdc76f53da1692b4
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
Background HIV Pre-exposure prophylaxis (PrEP) is the regular use of antiretroviral medication by people who are not infected with HIV to prevent seroconversion. Israel approved PrEP for continuous use in 2017, and Israeli Health Maintenance Organiza
Externí odkaz:
https://doaj.org/article/d46ff7462faf47819bfe08f06e0995cb
Autor:
Alexander Rouvinski, Ahuva Friedman, Saveliy Kirillov, Jordan Hannink Attal, Sujata Kumari, Jamal Fahoum, Reuven Wiener, Sophie Magen, Yevgeni Plotkin, Daniel Chemtob, Herve Bercovier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::411d001ba54c3dd5ae71d3850017a56b
https://doi.org/10.2139/ssrn.4399153
https://doi.org/10.2139/ssrn.4399153
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 11, p e0259168 (2021)
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259168 (2021)
PLoS ONE, Vol 16, Iss 11 (2021)
Background HIV Pre-exposure prophylaxis (PrEP) is the regular use of antiretroviral medication by people who are not infected with HIV to prevent seroconversion. Israel approved PrEP for continuous use in 2017, and Israeli Health Maintenance Organiza